You are here

Antibodies, Peptides, and Payload for Antibody Drug Conjugates

Overview: 

- Introduction to ADCs and CRUK’s biologics capabilities
- Summary of antibody opportunities
- Non-confidential information on antibodies to the following targets:

  • CEA
  • Muc1
  • CEACAM5/6
  • CD160
  • αvβ6 integrin
  • CALLA
  • TCR mimic antibodies (p53)
  • ICAM3
  • CCR4
  • CD45RO

- Novel toxic payload against CDC2L1/2

The Opportunity: 

A summary of all of our antibody and peptide opportunities can be found in the presentation linked below.

Contact: